The current classification of cutaneous malignant lymphomas (ML) into low-grade and high-grade lymphomas was found to be of limited reproducibility and permitted only a rough prediction about outcome. With this in mind, the relationship between nuclear DNA content and both prognosis and histologic grading according to the Kiel classification was evaluated on Feulgen-stained imprint specimens. In all, 49 cases of malignant non-Hodgkin's lymphoma, primary of the skin or with an involvement of the skin as one of the first symptoms, were studied using a computerized high-resolution image analysis system. The 2c deviation index (ZcDI), which reflects the variation of the nuclear DNA values around the normal diploid peak, was found to be the best prognostically relevant criterion. Using the ZcDI, a significant discrimination (P less than 0.001 in the U test) between low-grade and high-grade ML was achieved. The prognostic benefit of the 2cDI was well documented by a significant inverse correlation between the 2cDI and the period of time until the patients progressed at least into one higher stage or died of lymphoma (r equals -0.63, P less than 0.05). In addition, the 2cDI enabled prognosis of the course of disease. In the group with low 2cDI values (ZcDI, less than 0.5), no progression of the disease was observed after 1 year. In the groups presenting with a 2cDI between 0.5 and 1.0 and higher than 1.0, a progression was found in 57% and 64% of the cases studied, respectively. In conclusion, these measurements indicate that the determination of DNA distribution patterns in imprint specimens allows a precise and objective prognostic evaluation of cutaneous ML.
Kiel classification,] allow only a rough discrimination between low-grade and high-grade ML, which may not reflect the full range of biologic Grading of lymphomas according to morphologic features alone also is subjective and was shown to be insufficiently reprod~c i b l e .~,~ Moreover, approximately 15% of cutaneous ML do not fit into common classification scheme^.^ This was demonstrated in one study4 where there was identification of four prognostically relevant subgroups in mycosis fungoides (MF) alone: some of these cases had the same poor prognosis as high-grade lymphomas. In addition to histologic and immunohistologic findings, more objective and reliable criteria are necessary for an accurate prognostic evaluation of individual cases of ML.
It is widely accepted that malignant tumors often have abnormal nuclear DNA values and that DNA measure-Vol. 68 ments are very helpful for the prognostic and diagnostic evaluation of neoplasms of many To our knowledge, measurements of Feulgen-stained (Merk, Darmstadt, Germany) nuclei were used only for the diagnosis of cutaneous ML,I4-l7 not for the determination of prognostically relevant markers. Therefore, we used high-resolution image analy~is'".'~ of imprint preparations of cutaneous ML to examine the prognostic significance of DNA cytometry and its relationship to histologic grading.
Materials and Methods

Patients
The DNA measurements were done on imprint preparations of skin lesions of 49 cases of malignant nonHodgkin's lymphoma, primary of the skin or with an involvement of the skin as one of the first symptoms. The diagnoses were established by histologic, immunohistologic, and clinical criteria before DNA analysis. Because the Kiel classification' was not found to be reliable for grading of all low-grade malignant lymphoma^,^ cases with a predominance of medium-sized or large lymphocytes in the infiltrate were classified by two independent welltrained histopathologists into a group of intermediate grades of malignancy (Table 1) . According to this modified Kiel classification,' 23 of 49 cases were classified as lowgrade malignant lymphomas (1 2 of B-cell type and 1 1 of T-cell type); ten cases, as intermediate-grade (six of T-cell type, one of B-cell type, and three unclassified cases), and 16 as high-grade lymphomas (two of T-cell type, eight of B-cell type, four of neither B-cell nor T-cell types, and two unclassified cases; Table 1) .
Detailed staging procedures were done, including chest radiography, computed tomography, sonography, and if necessary, radionuclide imaging, and biopsies were taken of the bone marrow, liver, and lymph nodes. Stages were defined according to the tumor-node-metastasis (TNM) system.' Detailed data concerning diagnosis, histologic type, grading, age, and sex are given in Table 1 .
The interval between imprint preparation and progression to the next higher stage in the TNM system or death was known for I8 of the 49 patients. In these cases, it was possible to study the correlation between DNA data and progression.
Preparation of Imprints
Imprints were made by touching clean glass slides with the freshly cut surface of a skin biopsy specimen. Fixation of the imprints with methanol (loo%), formaldehyde (37%), and glacial acetic acid (96%) 85: 105 (v/v/v) and Feulgen staining were done according to Bohm.20 The imprints were hydrolyzed with 5 N HCl for 50 minutes at a constant temperature of 28°C and stained with Schiff s reagent for 60 minutes.
DNA Measurements
DNA analysis was done on the imprints using the highresolution video image-analysis system IPS (Kontron, Eching, Germany). The routine for DNA measurements (described in detail previously)2' allows a fully automatic segmentation of the nuclear area by using different steps of image processing such as gray-scale normalization and high-pass filtering.
Variables Calculated
For each nucleus, the optical density (OD) and the area were measured. The integrated optical density (IOD) was obtained by multiplying the OD by the area. In Feulgenstained nuclei, the IOD is correlated linearly with the DNA content. Twenty chicken erythrocytes were used as an internal reference on each slide. In a previous pilot study, a comparison of nuclei of chicken erythrocytes and normal human lymphocytes revealed that:
The 2c DNA represents the DNA content of a normal human diploid cell. A euploid cell in G2 contains 4c DNA. In this study, the relative DNA content of 100 randomly selected cells was calculated in each case as follows:
Algorithms for Data Evaluation
The discriminating power of the following features of the DNA histogram was evaluated using the Kontron software package:
The 2c deviation index (2cDI): The 2cDI was defined according to Backing el aL2* as the ratio between the sum of the squares of the differences between the DNA values of individual cells (ci) and the 2c value and the number of cells measured (N).
Roughly, the 2cDI reflects the variation of the nuclear DNA values around the 2c value for an individual patient.
The 5c exceeding rate (ScER): The 5cER was defined according to Bocking et a1.22 as the percentage of cells with a DNA content equal to or more than 5c. Because euploid-polyploid cells should not contribute to the ScER, all cells with DNA values that are integer-valued exponents of 2c * 12.5% are ignored. The maximum error of measurement was set at 12.5%.22 Thus, the 5cER identifies aneuploid cells only. 
Data Analysis
Statistical evaluation of the data was based on the Mann-Whitney's U test and the correlation ~oefficient.~~ Significance in both tests was defined as P less than 0.05. The reproducibility of DNA measurements was tested four times during the study by the demonstration of the different ploidy peaks in rat liver imprints.
Results
The best discrimination between low-grade and highgrade lymphomas was possible using the 2cDI (Fig. 1) . In the group of low-grade lymphomas, the 2cDI ranged from 0.05 to 0.8 I; in high-grade lymphomas, 2cDI values from 0.53 to 1 1.73 were observed. In the intermediate group, the 2cD1 was between 0.43 and 1.68. Statistically significant differences were found between low-grade and highgrade ML ( P less than 0.00 I), between intermediate-grade and low-grade ML (P less than O.OOl), and between the intermediate-grade and high-grade ML ( P less than 0.05). No significant differences were found between B-cell and T-cell lymphomas in either the low-grade or the intermediate-grade or high-grade groups of ML ( P more than 0.05). The determination of the 4cER also allowed significant discrimination between low-grade and intermediate-grade ML ( P less than 0. ML. Significant differences were not observed for the 5cER. Values between 0 and 4 were found in the lowgrade and intermediate-grade groups and between 0 and 10, in high-grade ML.
Not only was 2cDI a useful marker for differentiating between low-grade and high-grade ML; but the formula log,,(2cDIt 1) showed a significant inverse correlation ( r equals -0.63, P less than 0.05) to loglO(time) until progression to the next higher stage of the TNM scheme or death occurred. This also was found for low-grade lymphomas (Kiel) alone ( r equals 0.68, P less than 0.05); for high-grade lymphomas (Kiel), the correlation was not significant. For B-cell lymphomas alone, the correlation coefficient was even higher ( r equals -0.75, Fig. 2 ).
In addition, the 2cDI was a predictor of the course of the disease. None of the patients with a 2cDI lower than 0.5 had tumor progression within 1 year, whereas 57% and 64% of the patients with a 2cDI from 0.5 to 1.0 or higher than 1 .O, respectively, had to be assigned to a higher TNM stage after I year. Simultaneously, the percentage of patients with a remission under therapy decreased in the groups with higher 2cDI values (Fig. 3) .
The 2cDI also was useful for the prediction of mortality. In the group with initial 2cDI values below 0.5, all patients were still alive after 2 years, whereas the mortality rate was 30% in the group with a 2cDI between 0.5 and 1.0 and 45% in patients with a 2cDI exceeding 1 .O.
The 2cD1 showed a significant correlation with both the 4cER ( I equals 0.92, P less than 0.05) and the 5cER ( r equals 0.79, P less than 0.05). However, the 5cER and the 4cER did not provide additional prognostic information.
Discussion
The most impressive result in this cytometric study was the finding that calculation of the 2cDI allowed a significant discrimination between low-grade, intermediategrade, and high-grade lymphomas using a modified Kiel classification (P less than 0.05, by two-sided U test, Fig.   I ). Applying the 4cER as a criterion for grading, a difference was obtained between low-grade and high-grade lymphomas, but not between intermediate-grade and high-grade lymphomas because the zone of overlap between the groups was higher than using the 2cDI. The ScER, which represents the percentage of cells containing more than 5c DNA and is therefore an indicator for definite aneuploidy, was found to be an unreliable marker for grading. The 5cER seems to be more useful for the differentiating between benign and malignant lesions, as shown for cutaneous pseudolymphomas and malignant lymphomas,*' and for tumors of the breast, bone, prostate, and A prerequisite for grading strategies in the Kiel classification' or the New Working Formulation for clinical usage of the National Cancer Institute24 is that histomorphologically similar lymphomas have the same malignant potential. However, morphologically defined subgroups of malignant lymphomas often are heterogeneous in their clinical course and do not always have the same survival pr~bability.'-~ Different prognostically relevant subgroups of MF were defined because, with respect to survival probability, cases with many large and medium cells were more likely to represent high-grade than lowgrade lymphoma^.^ However, a major handicap for the broad application of such detailed classification strategies4 is the low interobserver reproducibility.6 In contrast to morphologic grading, the 2cDI is a more objective and reproducible parameter.*-3
Moreover, the currently applied histopathologic classification schemes, such as the Kiel classification or the New Working Formulation, allow discrimination only between two or three prognostic relevant groups. The 2cDI provides a continuous scale for grading of malignancy of individual lesions and has been established as a sensitive feature for grading and diagnosis of tumors of the bone, cervix, breast, prostate, and nodular lymphoma^.',^.^' To our knowledge, the prognostic impact of DNA distribution pattern has not been demonstrated in cutaneous ML.
The calculation of the 2cDI using imprint investigation with an image-analysis system does not require a welltrained histopathologist with great experience in the field of ML; it can be done with the same accuracy by a technician. However, the procedure is more time consuming than detailed histopathologic examination.
The relevance of this newly described grading parameter for cutaneous ML has to be demonstrated by its clinical impact. We found a significant correlation between the 10g,~(2cDI+ 1) and the loglo of the time elapsed until the next higher TNM stage was reached or death occurred. This correlation also was significant in the low-grade group alone. This indicates a heterogeneous prognosis in a morphologically defined subgroup and stresses the advantage of the 2cDI for prognostic evaluation. In these low-grade cases, 5cER was always lower than 576, and the benefit of the 2cDI was not based on the presence of numerous aneuploid nuclei with DNA values higher than 5c, but on the increase of proliferative nuclei with relative DNA values between 2 . 2 5~ and 3 . 5~. Because ofthe low number of high-grade lymphomas with sufficient prognostic data, a significant correlation could not be calculated in these cases. Using the regression line in Figure 2 , the individual risk ofthe patients can be determined more precisely than by applying the rough discrimination into low-grade, intermediate-grade, and high-grade lymphomas. Moreover, without respect to histomorphology, the 2cDI enabled discrimination between three groups of patients with different progression rates (Fig. 3) .
The nuclear area frequently is well correlated with the nuclear DNA content,*' and morphometric techniques alone (which can be done more rapidly already using lowcost image analysis systems or point sampling methods as described recently for malignant melanomas)26 also might be clinically beneficial. In the Netherlands, a multicenter study was begun to evaluate the benefits of morphometric measurements in histologic sections of breast cancer.*' These authors showed that about 22% of patients received a more appropriate therapy with than without morphometric data.
Cytochemical and immunologic cell typing28-35 also might allow a more detailed prognostic analysis in cuta- Vol. 68 neous ML. One study described the use of the monoclonal antibody Ki-67, reported to be well correlated with the growth fraction of cell populations, which therefore might be an additional predictor of prognosis in human tum o r~.~' Using the Ki-1 antibody, a new and distinct entity among the cutaneous lymphomas was defined that could not be characterized by morphologic features alone. 33 However, for most of the cutaneous malignant lymphomas, prognostically significant antibodies are of limited value, and further experience must be gained with this te~hnique.'~ For evaluating the full benefit of DNA measurements for predicting prognosis in cutaneous ML, as indicated by our study, long-term prospective and retrospective studies of more patients are necessary. Such investigations already have been done for mammary adenocarcinomal' and nodular lymph~ma.'.~
The development of techniques for the production of single-cell specimens from paraffin-embedded material36 now has made these studies easier. High-resolution image analysis of the chromatin structure, altered even in preneoplastic therefore may be superior to pure ploidy analysis and may improve the grading of ML.
